PLAAT3 and osteosarcoma: Recently, we have also demonstrated that increased expression levels of PLA2G16 mediated by mutant p53 contribute to osteosarcoma progression and metastasis [4].It will be very interesting to investigate whether p53 mutations in osteosarcoma correlate with the expression of PLA2G16.